The role of fructose in metabolism and cancer

Bérénice Charrez 1 , Liang Qiao 1 ,  and Lionel Hebbard 1
  • 1 Storr Liver Centre, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, NSW, Australia
Bérénice Charrez, Liang Qiao and Lionel Hebbard

Abstract

Fructose consumption has dramatically increased in the last 30 years. The principal form has been in the form of high-fructose corn syrup found in soft drinks and processed food. The effect of excessive fructose consumption on human health is only beginning to be understood. Fructose has been confirmed to induce several obesity-related complications associated with the metabolic syndrome. Here we present an overview of fructose metabolism and how it contrasts with that of glucose. In addition, we examine how excessive fructose consumption can affect de novo lipogenesis, insulin resistance, inflammation, and reactive oxygen species production. Fructose can also induce a change in the gut permeability and promote the release of inflammatory factors to the liver, which has potential implications in increasing hepatic inflammation. Moreover, fructose has been associated with colon, pancreas, and liver cancers, and we shall discuss the evidence for these observations. Taken together, data suggest that sustained fructose consumption should be curtailed as it is detrimental to long-term human health.

  • 1.

    World Health Organization Fact Sheet. Obesity and overweight. 2014; No. 311.

  • 2.

    Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78.

    • Crossref
    • Export Citation
  • 3.

    Hebbard L, George J. Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2011;8:35–44.

    • Crossref
    • Export Citation
  • 4.

    Agren R, Bordel S, Mardinoglu A, Pornputtapong N, Nookaew I, Nielsen J. Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput Biol 2012;8:e1002518.

    • Crossref
    • Export Citation
  • 5.

    Lichtenstein A, Kennedy E, Barrier P, Danford D, Ernst N, Grundy S, Leveille G, Van Horn L, Williams C, Booth S. Dietary fat consumption and health. Nutr Rev 1998;56:S3–19.

    • Crossref
    • Export Citation
  • 6.

    Haley S, Reed J, Lin B-H, Cook A. Sweetener consumption in the United States: distribution by demographic and product characteristics. Washington, DC: Economic Research Service Electronic Outlook Report USDA Economic Research Service, 2005.

  • 7.

    Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004;79:537–43.

    • Crossref
    • PubMed
    • Export Citation
  • 8.

    Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010;90:23–46.

    • Crossref
    • PubMed
    • Export Citation
  • 9.

    Port AM, Ruth MR, Istfan NW. Fructose consumption and cancer: is there a connection? Curr Opin Endocrinol Diabetes Obes 2012;19:367–74.

    • Crossref
    • Export Citation
  • 10.

    Bray GA. Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. Adv Nutr 2013;4:220–5.

    • Crossref
    • Export Citation
  • 11.

    Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009;51:918–24.

    • Crossref
    • Export Citation
  • 12.

    Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. J Am Med Assoc 2004;292:927–34.

    • Crossref
    • Export Citation
  • 13.

    Hevener AL, Febbraio MA, Stock Conference Working Group. The 2009 stock conference report: inflammation, obesity and metabolic disease. Obes Rev 2010;11:635–44.

    • Crossref
    • Export Citation
  • 14.

    Samuel VT. Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab 2011;22:60–5.

    • Crossref
    • Export Citation
  • 15.

    Payne AN, Chassard C, Lacroix C. Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. Obes Rev 2012;13:799–809.

    • Crossref
    • Export Citation
  • 16.

    Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger GR, Chandel NS. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA 2010;107:8788–93.

    • Crossref
    • Export Citation
  • 17.

    Foray F, Hollander D, Mcpherson JD, Shilton BH, Walton DJ. Role of fructose in glycation and cross-linking of proteins. Biochemistry 1988;27:1901–7.

    • Crossref
    • Export Citation
  • 18.

    Nomura K, Yamanouchi T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem 2012;23:203–8.

    • PubMed
    • Export Citation
  • 19.

    Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, Sacks F, Steffen LM, Wylie-Rosett J, American Heart Association Nutrition Committee of the Council on Nutrition PA, Metabolism, the Council on E, Prevention. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2009;120:1011–20.

    • Crossref
    • Export Citation
  • 20.

    van der Borght K, Kohnke R, Goransson N, Deierborg T, Brundin P, Erlanson-Albertsson C, Lindqvist A. Reduced neurogenesis in the rat hippocampus following high fructose consumption. Regul Pept 2011;167:26–30.

    • Crossref
    • Export Citation
  • 21.

    Theytaz F, de Giorgi S, Hodson L, Stefanoni N, Rey V, Schneiter P, Giusti V, Tappy L. Metabolic fate of fructose ingested with and without glucose in a mixed meal. Nutrients 2014;6:2632–49.

    • Crossref
    • Export Citation
  • 22.

    McQuade DT, Plutschack MB, Seeberger PH. Passive fructose transporters in disease: a molecular overview of their structural specificity. Org Biomol Chem 2013;11:4909–20.

    • Crossref
    • Export Citation
  • 23.

    Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002;76:911–22.

    • Crossref
    • Export Citation
  • 24.

    Wilder-Smith CH, Li X, Ho SS, Leong SM, Wong RK, Koay ES, Ferraris RP. Fructose transporters GLUT5 and GLUT2 expression in adult patients with fructose intolerance. United European Gastroenterol J 2014;2:14–21.

    • Crossref
    • Export Citation
  • 25.

    Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005;63:133–57.

    • Crossref
    • PubMed
    • Export Citation
  • 26.

    Cantley LC. Cancer, metabolism, fructose, artificial sweeteners, and going cold turkey on sugar. BMC Biol 2014;12:8.

  • 27.

    Vos MB, Lavine JE. Dietary fructose in nonalcoholic fatty liver disease. Hepatology 2013;57:2525–31.

    • Crossref
    • Export Citation
  • 28.

    Kretowicz M, Johnson RJ, Ishimoto T, Nakagawa T, Manitius J. The impact of fructose on renal function and blood pressure. Int J Nephrol 2011;2011:315879.

    • Crossref
    • PubMed
    • Export Citation
  • 29.

    Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058–70.

    • Crossref
    • Export Citation
  • 30.

    Lanaspa MA, Ishimoto T, Li N, Cicerchi C, Orlicky DJ, Ruzycki P, Rivard C, Inaba S, Roncal-Jimenez CA, Bales ES, Diggle CP, Asipu A, Petrash JM, Kosugi T, Maruyama S, Sanchez-Lozada LG, McManaman JL, Bonthron DT, Sautin YY, Johnson RJ. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun 2013;4:2434.

    • Crossref
    • Export Citation
  • 31.

    Ishimoto T, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Orlicky DJ, Cicerchi C, McMahan RH, Abdelmalek MF, Rosen HR, Jackman MR, MacLean PS, Diggle CP, Asipu A, Inaba S, Kosugi T, Sato W, Maruyama S, Sanchez-Lozada LG, Sautin YY, Hill JO, Bonthron DT, Johnson RJ. High-fat and high-sucrose (Western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology 2013;58:1632–43.

    • Crossref
    • PubMed
    • Export Citation
  • 32.

    Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322–34.

    • Crossref
    • Export Citation
  • 33.

    Robubi A, Huber KR, Krugluger W. Extra fructose in the growth medium fuels lipogenesis of adipocytes. J Obes 2014;2014:647034.

    • Crossref
    • PubMed
    • Export Citation
  • 34.

    Park OJ, Cesar D, Faix D, Wu K, Shackleton CH, Hellerstein MK. Mechanisms of fructose-induced hypertriglyceridaemia in the rat: activation of hepatic pyruvate dehydrogenase through inhibition of pyruvate dehydrogenase kinase. Biochem J 1992;282:753–7.

    • Crossref
    • Export Citation
  • 35.

    Nagai Y, Yonemitsu S, Erion DM, Iwasaki T, Stark R, Weismann D, Dong J, Zhang D, Jurczak MJ, Loffler MG, Cresswell J, Yu XX, Murray SF, Bhanot S, Monia BP, Bogan JS, Samuel V, Shulman GI. The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Cell Metab 2009;9:252–64.

    • Crossref
    • Export Citation
  • 36.

    Velickovic N, Djordjevic A, Vasiljevic A, Bursac B, Milutinovic DV, Matic G. Tissue-specific regulation of inflammation by macrophage migration inhibitory factor and glucocorticoids in fructose-fed Wistar rats. Br J Nutr 2013;110:456–65.

    • Crossref
    • Export Citation
  • 37.

    Roglans N, Vilà L, Farré M, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC. Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 2007;45:778–88.

    • Crossref
    • Export Citation
  • 38.

    Alwahsh SM, Xu M, Seyhan HA, Ahmad S, Mihm S, Ramadori G, Schultze FC. Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver. World J Gastroenterol 2014;20:1807–21.

    • Crossref
    • Export Citation
  • 39.

    Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 2009;50:1094–104.

    • Crossref
    • Export Citation
  • 40.

    Bergheim I, Weber S, Vos M, Kramer S, Volynets V, Kaserouni S, McClain CJ, Bischoff SC. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 2008;48:983–92.

    • Crossref
    • PubMed
    • Export Citation
  • 41.

    Spruss A, Kanuri G, Stahl C, Bischoff SC, Bergheim I. Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. Lab Invest 2012;92:1020–32.

    • Crossref
    • PubMed
    • Export Citation
  • 42.

    Johnson RJ, Rivard C, Lanaspa MA, Otabachian-Smith S, Ishimoto T, Cicerchi C, Cheeke PR, Macintosh B, Hess T. Fructokinase, fructans, intestinal permeability, and metabolic syndrome: an equine connection? J Equine Vet Sci 2013;33:120–6.

    • Crossref
    • PubMed
    • Export Citation
  • 43.

    Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010;375:2267–77.

    • Crossref
    • Export Citation
  • 44.

    Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell 2012;148:852–71.

    • Crossref
    • Export Citation
  • 45.

    Le KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 2009;89: 1760–5.

    • Crossref
    • Export Citation
  • 46.

    Faeh D, Minehira K, Schwarz JM, Periasamy R, Park S, Tappy L. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 2005;54:1907–13.

    • Crossref
    • Export Citation
  • 47.

    Aeberli I, Hochuli M, Gerber PA, Sze L, Murer SB, Tappy L, Spinas GA, Berneis K. Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial. Diabetes Care 2013;36:150–6.

    • Crossref
    • Export Citation
  • 48.

    Chan SM, Sun RQ, Zeng XY, Choong ZH, Wang H, Watt MJ, Ye JM. Activation of PPARalpha ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes 2013;62:2095–105.

    • Crossref
    • PubMed
    • Export Citation
  • 49.

    Zawalich WS, Rognstad R, Pagliara AS, Matschinsky FM. A comparison of the utilization rates and hormone-releasing actions of glucose, mannose, and fructose in isolated pancreatic islets. Journal Biol Chem 1977;252:8519–23.

  • 50.

    Bailey CJ, Day C, Knapper JM, Turner SL, Flatt PR. Antihyperglycaemic effect of saccharin in diabetic ob/ob mice. Br J Pharmacol 1997;120:74–8.

  • 51.

    Malaisse WJ, Vanonderbergen A, Louchami K, Jijakli H, Malaisse-Lagae F. Effects of artificial sweeteners on insulin release and cationic fluxes in rat pancreatic islets. Cellular Signal 1998;10:727–33.

  • 52.

    Kyriazis GA, Soundarapandian MM, Tyrberg B. Sweet taste receptor signaling in beta cells mediates fructose-induced potentiation of glucose-stimulated insulin secretion. Proc Natl Acad Sci USA 2012;109:E524–32.

    • Crossref
    • Export Citation
  • 53.

    Koo HY, Wallig MA, Chung BH, Nara TY, Cho BH, Nakamura MT. Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. Biochim Biophys Acta 2008;1782:341–8.

  • 54.

    Stirpe F, Della Corte E, Bonetti E, Abbondanza A, Abbati A, De Stefano F. Fructose-induced hyperuricaemia. Lancet 1970;2:1310–1.

    • Crossref
    • Export Citation
  • 55.

    Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006;290:F625–31.

    • Crossref
    • Export Citation
  • 56.

    Dills WL, Jr. Protein fructosylation: fructose and the Maillard reaction. Am J Clin Nutr 1993;58(Suppl 5):779S–87S.

    • Crossref
    • Export Citation
  • 57.

    Bunn HF, Higgins PJ. Reaction of monosaccharides with proteins: possible evolutionary significance. Science 1981;213:222–4.

    • Crossref
    • Export Citation
  • 58.

    Bose T, Chakraborti AS. Fructose-induced structural and functional modifications of hemoglobin: implication for oxidative stress in diabetes mellitus. Biochim Biophys Acta 2008;1780:800–8.

    • PubMed
    • Export Citation
  • 59.

    Shangari N, O’Brien PJ. The cytotoxic mechanism of glyoxal involves oxidative stress. Biochem Pharmacol 2004;68:1433–42.

    • Crossref
    • PubMed
    • Export Citation
  • 60.

    Feng CY, Wong S, Dong Q, Bruce J, Mehta R, Bruce WR, O’Brien PJ. Hepatocyte inflammation model for cytotoxicity research: fructose or glycolaldehyde as a source of endogenous toxins. Arch Physiol Biochem 2009;115:105–11.

    • Crossref
    • PubMed
    • Export Citation
  • 61.

    Lee O, Bruce WR, Dong Q, Bruce J, Mehta R, O’Brien PJ. Fructose and carbonyl metabolites as endogenous toxins. Chem Biol Interact 2009;178:332–9.

    • Crossref
    • Export Citation
  • 62.

    Crescenzo R, Bianco F, Falcone I, Coppola P, Liverini G, Iossa S. Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose. Eur J Nutr 2013;52:537–45.

    • Crossref
    • Export Citation
  • 63.

    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US. adults. N Engl J Med 2003;348:1625–38.

    • Crossref
    • Export Citation
  • 64.

    Parekh N, Chandran U, Bandera EV. Obesity in cancer survival. Annu Rev Nutr 2012;32:311–42.

    • Crossref
    • Export Citation
  • 65.

    Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011;11:325–37.

    • Crossref
    • PubMed
    • Export Citation
  • 66.

    Meyerhardt JA, Sato K, Niedzwiecki D, Ye C, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Wigler DS, Venook A, Fuchs CS. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst 2012;104:1702–11.

  • 67.

    Michaud DS, Fuchs CS, Liu S, Willett WC, Colditz GA, Giovannucci E. Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2005;14:138–47.

  • 68.

    Higginbotham S, Zhang ZF, Lee IM, Cook NR, Giovannucci E, Buring JE, Liu S, Women’s Health S. Dietary glycemic load and risk of colorectal cancer in the Women’s Health Study. J Natl Cancer Inst 2004;96:229–33.

    • Crossref
    • Export Citation
  • 69.

    Stamp D, Zhang XM, Medline A, Bruce WR, Archer MC. Sucrose enhancement of the early steps of colon carcinogenesis in mice. Carcinogenesis 1993;14:777–9.

    • Crossref
    • PubMed
    • Export Citation
  • 70.

    Jacobsen H, Poulsen M, Dragsted LO, Ravn-Haren G, Meyer O, Lindecrona RH. Carbohydrate digestibility predicts colon carcinogenesis in azoxymethane-treated rats. Nutr Cancer 2006;55:163–70.

    • Crossref
    • PubMed
    • Export Citation
  • 71.

    Jiao L, Flood A, Subar AF, Hollenbeck AR, Schatzkin A, Stolzenberg-Solomon R. Glycemic index, carbohydrates, glycemic load, and the risk of pancreatic cancer in a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2009;18:1144–51.

    • Crossref
    • Export Citation
  • 72.

    Simon E, Joseph AJ, Choudhrie L, Eapen A, Vyas F, Sitaram V, Ramakrishna BS, Chacko A. Intraductal papillary mucinous neoplasm of the pancreas. Ind J gastroenterol 2010;29:40.

    • Crossref
    • Export Citation
  • 73.

    Liu H, Huang D, McArthur DL, Boros LG, Nissen N, Heaney AP. Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer Res 2010;70:6368–76.

    • Crossref
    • PubMed
    • Export Citation
  • 74.

    Cabibbo G, Craxi A. Epidemiology, risk factors and surveillance of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 2010;14:352–5.

  • 75.

    Hashimoto E, Yatsuji S, Tobari M, Taniai M, Torii N, Tokushige K, Shiratori K. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 2009;44(Suppl 19):89–95.

    • Crossref
    • Export Citation
  • 76.

    Sanyal A, Poklepovic A, Moyneur E, Barghout V. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin 2010;26:2183–91.

    • Crossref
    • Export Citation
  • 77.

    Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011;141:1249–53.

    • Crossref
    • Export Citation
  • 78.

    Kawada N, Imanaka K, Kawaguchi T, Tamai C, Ishihara R, Matsunaga T, Gotoh K, Yamada T, Tomita Y. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol 2009;44:1190–4.

    • Crossref
    • PubMed
    • Export Citation
  • 79.

    Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010;51:1820–32.

    • Crossref
    • PubMed
    • Export Citation
  • 80.

    Karagozian R, Derdak Z, Baffy G. Obesity-associated mechanisms of hepatocarcinogenesis. Metabolism 2014;63:607–17.

    • Crossref
    • Export Citation
  • 81.

    Enzmann H, Ohlhauser D, Dettler T, Bannasch P. Enhancement of hepatocarcinogenesis in rats by dietary fructose. Carcinogenesis 1989;10:1247–52.

    • PubMed
    • Export Citation
  • 82.

    Kumamoto R, Uto H, Oda K, Ibusuki R, Tanoue S, Arima S, Mawatari S, Kumagai K, Numata M, Tamai T, Moriuchi A, Fujita H, Oketani M, Ido A, Tsubouchi H. Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat. Eur J Med Res 2013;18:54.

    • Crossref
    • Export Citation
  • 83.

    Healy ME, Chow JD, Byrne FL, Breen DS, Leitinger N, Li C, Lackner C, Caldwell SH, Hoehn KL. Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine. J Hepatol 2015;62:599–606.

    • Crossref
    • Export Citation
  • 84.

    Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A, Grosovski M. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 2008;22:811–6.

    • Crossref
    • PubMed
    • Export Citation
Purchase article
Get instant unlimited access to the article.
$42.00
Log in
Already have access? Please log in.


or
Log in with your institution

Journal + Issues

Hormone Molecular Biology and Clinical Investigation is dedicated to the provision of data on molecular aspects of hormones in physiology and pathophysiology. The journal covers the treatment of diseases, such as endocrine cancers, renal and lymphoid carcinoma, hypertension, cardiovascular systems, osteoporosis, hormone deficiency in menopause and andropause, obesity, diabetes, brain and related diseases.

Search